Subscribe
shutterstock_1857404794_michael_vi
Michael Vi / Shutterstock.com
12 January 2021AmericasMuireann Bolger

Illumina accused of fraud in DNA tech patents dispute

Illumina tried to secure its control over the DNA sequencing technology market by violating antitrust law, according to a suit by BGI Americas and two of its subsidiaries, at the US Court for the District Court of San Francisco.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Europe
Illumina files for patent infringement over prenatal test
8 September 2017   Genetic sequencing company Illumina has filed a patent infringement suit against Premaitha Health, a molecular diagnostics company, in the English High Court.
Americas
Illumina and Cornell University seek to dismiss patent dispute
20 April 2017   Genetic sequencing company Illumina and Cornell University have together sought to dismiss a patent dispute over eight genetic testing patents belonging to Cornell.


Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024

Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024
Americas
Comparing life sciences IP in Brazil and the US
28 November 2024
Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024
Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024
Americas
Big Pharma counsel embrace AI but data and legal risks loom
24 October 2024
Asia
President Xi sends message to AIPPI’s World Congress
22 October 2024

More on this story

Europe
Illumina files for patent infringement over prenatal test
8 September 2017   Genetic sequencing company Illumina has filed a patent infringement suit against Premaitha Health, a molecular diagnostics company, in the English High Court.
Americas
Illumina and Cornell University seek to dismiss patent dispute
20 April 2017   Genetic sequencing company Illumina and Cornell University have together sought to dismiss a patent dispute over eight genetic testing patents belonging to Cornell.

More on this story

Europe
Illumina files for patent infringement over prenatal test
8 September 2017   Genetic sequencing company Illumina has filed a patent infringement suit against Premaitha Health, a molecular diagnostics company, in the English High Court.
Americas
Illumina and Cornell University seek to dismiss patent dispute
20 April 2017   Genetic sequencing company Illumina and Cornell University have together sought to dismiss a patent dispute over eight genetic testing patents belonging to Cornell.

More features

Fed Circ orders Teva to delist five patents from Orange Book
Sarepta wins $115M in patent dispute over muscular dystrophy drug
Novartis shields eye-drop patent at European Patent Office
CREATES Act unfairly tips the scales to generics
LSPN launches its first-ever US awards to celebrate life sciences leaders
Pharma giants seek closure on COVID-19 vaccine rows
How Inhibrx defended a $450m damages suit
Foley & Lardner adds litigation and transaction expert in New York